Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay ; volume:9 ; number:1 ; day:6 ; month:3 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (6.3.2019), 1-10, 12.2019

Creator: Saludes, V.
Antuori, A.
Reinhardt, B.
Viciana, I.
Clavijo, E.
Schreiber, L.
Tenenbaum, M.
Rodriguez-Frias, F.
Quer, J.
Matas, L.
Martró, E.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-019-40099-3

URN: urn:nbn:de:101:1-2019032521223104543733

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Saludes, V.
Antuori, A.
Reinhardt, B.
Viciana, I.
Clavijo, E.
Schreiber, L.
Tenenbaum, M.
Rodriguez-Frias, F.
Quer, J.
Matas, L.
Martró, E.
SpringerLink (Online service)

Other Objects (12)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

New insight into HCV E1/E2 region of genotype 4a

Consensus siRNA for inhibition of HCV genotype-4 replication

Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genotype × environment interactions

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Related objects

Reset password